PD 0325901
Tocris Bioscience, part of Bio-Techne | Catalog # 4192
Potent inhibitor of MEK1/2
Key Product Details
Description
Potent inhibitor of MEK1/2
Alternative Names
PD325901
Product Description
PD 0325901 is a potent MEK1 and MEK2 inhibitor. PD 0325901 inhibits MEK activity in mouse colon 26 cells (IC50 = 0.33 nM). PD 0325901 inhibits the growth of melanoma cell lines in vitro and in vivo; induces G1-phase cell cycle arrest and apoptosis in a mouse xenograft model. PD 0325901 also inhibits production of proangiogenic cytokines such as VEGF. PD 0325901 enhances generation of induced pluripotent stem cells (iPSCs). PD 0325901 in combination with Vitamin C sustains mouse ES cells at an undifferentiated and hypomethylated state. PD 0325901 promotes myelin recovery in drug-induced demyelination in vivo in mice model. Orally bioavailable. Used in protocols for the generation of CiPSCs from MEFs, induction of cortical neurons from hiPSCs, and culture of mESCs (see below).For more information about how PD 0325901 may be used, see our protocols: Culturing Transcriptomically Distinct Pluripotent mESCs, Highly Efficient Generation of CiPSCs from MEFs, Accelerated Induction of Cortical Neurons from hiPSCs.
Licensing Information
Sold for research purposes under agreement from Pfizer Inc.Product Specifications
Molecular Weight
482.19
Formula
C16H14F3IN2O4
Storage
Store at -20°C
Purity
≥99% (HPLC)
Chemical Name
N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide
CAS Number
391210-10-9
PubChem ID
9826528
InChI Key
SUDAHWBOROXANE-SECBINFHSA-N
SMILES
FC1=CC(I)=CC=C1NC2=C(C(NOC[C@H](O)CO)=O)C=CC(F)=C2F
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 12.05 | 25 |
Preparing Stock Solutions
for PD 0325901
The following data is based on the product molecular weight 482.19
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.25 mM | 8.30 mL | 41.48 mL | 82.95 mL |
| 1.25 mM | 1.66 mL | 8.30 mL | 16.59 mL |
| 2.5 mM | 0.83 mL | 4.15 mL | 8.30 mL |
| 12.5 mM | 0.17 mL | 0.83 mL | 1.66 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Li An alternative culture method to maintain genomic hypomethylation of mouse embryonic stem cells using MEK inhibitor PD0325901 and vitamin C. J.Vis.Exp. 2018 PMID: 29912180
- Suo Inhibition of MAPK/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases. Glia 2019 PMID: 30815939
- Koehler 3D mouse embryonic stem cell culture for generating inner ear organoids. Nat.Protoc. 2014 PMID: 24784820
- Lin A chemical platform for improved induction of human iPSCs. Nat.Methods. 2009 PMID: 19838168
- Sebolt-Leopold The biological profile of PD 0325901: a second generation analog of CI-1040 with improved pharmaceutical potential. Proc.Amer.Assoc.Cancer Res.
- Ciuffreda Growth-inhibitor and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations. Neoplasia 2009 PMID: 19649202
- Barrett The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901. Bioorg.Med.Chem.Lett. 2008 PMID: 18952427
Product Specific Notices for PD 0325901
For research use only
Loading...
Loading...
Loading...